Urinary A- and C-megalin predict progression of diabetic kidney disease: an exploratory retrospective cohort study

Tomomichi Iida1, Michihiro Hosojima2, Hideyuki Kabasawa2

  • 1Department of Applied Molecular Medicine, Kidney Research Center, Niigata University Graduate School of Medical and Dental Sciences, 1-757 Asahimachi-dori, Chuo-ku, Niigata City, Niigata 951-8510, Japan; Division of Clinical Nephrology and Rheumatology, Kidney Research Center, Niigata University Graduate School of Medical and Dental Sciences, 1-757 Asahimachi-dori, Chuo-ku, Niigata City, Niigata 951-8510, Japan.

Abstract

Insights

Urinary megalin, in both ectodomain (A-megalin) and full-length (C-megalin) forms, shows promise as an independent prognostic biomarker for diabetic kidney disease (DKD) progression.

Area of Science:

  • Nephrology
  • Endocrinology
  • Biomarker Discovery

Background:

  • Diabetic kidney disease (DKD) is a major complication of diabetes.
  • Early and accurate prognostic biomarkers are crucial for managing DKD progression.
  • Megalin, a proximal tubular receptor, is excreted in urine in two forms: A-megalin and C-megalin.

Purpose of the Study:

  • To investigate the potential of urinary megalin levels as independent prognostic biomarkers for DKD progression.
  • To assess the association between urinary A-megalin/creatinine and C-megalin/creatinine levels and the estimated glomerular filtration rate (eGFR) slope.

Main Methods:

  • Retrospective analysis of 188 patients with type 2 diabetes.
  • Generalized estimating equation used to analyze associations between urinary megalin levels and eGFR slope.
  • Patients categorized into higher/lower groups based on ROC curve-derived cutoff values for A-megalin/Cr and C-megalin/Cr.

Main Results:

  • Higher urinary A-megalin/Cr and C-megalin/Cr levels were associated with steeper eGFR decline (-0.904 and -0.749 ml/min/1.73 m²/year, respectively).
  • Combined higher levels of both forms showed a significantly steeper eGFR slope (-1.888 ml/min/1.73 m²/year).
  • These associations remained significant after adjusting for other urinary biomarkers.

Conclusions:

  • Urinary A-megalin/Cr and C-megalin/Cr are potential independent prognostic biomarkers for DKD progression.
  • Megalin levels in urine may offer valuable insights into DKD trajectory beyond traditional biomarkers.

Related Concept Videos

Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
56
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
70
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
53
Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
143
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
16
Urinary Tract Calculi III: Medical Management01:30

Urinary Tract Calculi III: Medical Management

The diagnosis of renal calculi involves several imaging techniques, including non-contrast CT scans and ultrasound. These methods help visualize kidney stones, assess their size and location, and detect possible obstructions. Additionally, Measuring urine pH is useful for diagnosing specific stone types, such as struvite (alkaline pH) and uric acid stones (acidic pH). Cystine stones are primarily linked to cystinuria, a genetic condition. A urinalysis helps detect blood in the urine (hematuria)...
16